Federation des caisses Desjardins du Quebec’s VanEck Biotech ETF BBH Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-300	Closed	-$49.9K	–	2497
2024 Q1	$49.9K	Hold	300	–	–	﹤0.01%	1407
2023 Q4	$49.6K	Hold	300	–	–	﹤0.01%	1311
2023 Q3	$46.7K	Hold	300	–	–	﹤0.01%	1325
2023 Q2	$46.8K	Hold	300	–	–	﹤0.01%	1350
2023 Q1	$48.6K	Hold	300	–	–	﹤0.01%	1332
2022 Q4	$47.9K	Hold	300	–	–	﹤0.01%	1457
2022 Q3	$42.2K	Hold	300	–	–	﹤0.01%	1550
2022 Q2	$43.7K	Hold	300	–	–	﹤0.01%	1556
2022 Q1	$48.6K	Hold	300	–	–	﹤0.01%	1597
2021 Q4	$56.8K	Hold	300	–	–	﹤0.01%	1562
2021 Q3	$60.6K	Buy	+300	New	+$63K	﹤0.01%	1547

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BBH Position: Q2 2024 in Review

Federation des caisses Desjardins du Quebec sold out of VanEck Biotech ETF (BBH) in Q2 2024, closing a stake of 300 shares — an estimated $49.9K sold.

Federation des caisses Desjardins du Quebec first reported a position in BBH in Q3 2021 and held it in 11 quarters. The position peaked at $60.6K in Q3 2021. 116 funds tracked by Wall St. Rank hold BBH as of Q2 2024.

Federation des caisses Desjardins du Quebec reported no remaining VanEck Biotech ETF position as of Q2 2024 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 300 VanEck Biotech ETF shares in Q2 2024, an estimated $49.9K.
Federation des caisses Desjardins du Quebec first reported a position in VanEck Biotech ETF in Q3 2021 and held it in 11 quarters.
Federation des caisses Desjardins du Quebec's VanEck Biotech ETF position peaked at $60.6K in Q3 2021.
116 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2024.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2024, filed 14 Aug 2024.